Changes to the website
Sponsored By
AbbVie
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4914

Next 25
Website Changes
01/21/2020 Multimodal Surgical Treatment of High-Grade Gliomas in the Motor Area: The Impact of the Combination of Navigated Transcranial Magnetic Stimulation and Fluorescein-Guided Resection.
01/21/2020 Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1
01/21/2020 Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling
01/21/2020 Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
01/15/2020 Musella Foundation Brain Tumor Copay program is now open!
01/15/2020 Scientists breach brain barriers to attack tumors
01/13/2020 Medicenna Vaults on Brain Cancer Study
01/10/2020 Optimal adjuvant therapy in elderly glioblastoma: results from a systematic review and network meta-analysis
01/10/2020 Surgery may add months or years of survival for adults with rare and deadly brain cancers
01/09/2020 Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide.
01/08/2020 New book takes a humorous look at brain cancer
01/08/2020 Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma.
01/07/2020 DIPG Advocacy Group Announces Congressional Briefing for Pediatric Brain Cancer
01/06/2020 Musella Foundation Awards $250,000 Brain Tumor Research Grant
01/05/2020 Mount Sinai Receives More Than $10 Million in Grant Funding for Brain Tumor Research
01/04/2020 Complete radiological response following subtotal resection in three glioblastoma patients under treatment with Tumor Treating Fields.
01/04/2020 Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences?
01/04/2020 Cost-effectiveness analysis of the addition of bevacizumab to temozolomide therapy for the treatment of unresected glioblastoma.
12/28/2019 Made website more accessable! Click the logo on top right of any page to see!
12/25/2019 Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma.
12/25/2019 A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).
12/25/2019 Safety and efficacy of VB-111, an anti-cancer gene-therapy, in patients with recurrent glioblastoma: results of a phase I/II study
12/16/2019 Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.
12/03/2019 Musella Foundation`s Annual Giving Campaign
12/03/2019 SNO 2019: The Oncolytic Herpes Virus G47? May Lead to a Potential Cure of Malignant Glioma



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740